Fig. 5
- ID
- ZDB-FIG-220623-41
- Publication
- Georgantzoglou et al., 2022 - A two-step search and run response to gradients shapes leukocyte navigation in vivo
- Other Figures
- All Figure Page
- Back to All Figure Page
Differential contributions of Arp2/3 and Myosin-II in gradient responses. (A) Top row: Two-photon time-lapse image projections showing neutrophils in Tg(mpx:Lifeact-Ruby) zebrafish larvae treated with DMSO, CK666, and Blebbistatin, where the cell front has been segmented automatically (red lines). Bottom row: Example neutrophil treated with Blebbistatin, with new leading edge forming at the cell lateral/rear towards the LW (red arrow). White arrow indicates the cell’s direction of migration. Triangle indicates the direction of LW (not in the field of view). Scale bar = 10 μm. (B) Average surface area of the cell front part with DMSO, CK666, and Blebbistatin treatments. One-way ANOVA with Dunnett’s multiple comparisons test, * P = 0.0138 (DMSO-CK666 pre-LW), P = 0.0437 (CK666-Blebbistatin pre-LW), P = 0.0379 (DMSO-CK666 post-LW). (C) Percentage of cells that generate a new leading edge from the rear or the side of their body, for the treatments of DMSO, CK666, and Blebbistatin, respectively. Chi-square test, ****, P < 0.0001. (D) Average time that cells spend in search (front Lifeact enrichment) and running (rear Lifeact enrichment) phase, for the treatments of DMSO, CK666 and Blebbistatin, respectively, for pre- (left) and post-LW (right). Kruskal-Wallis test with Dunn’s multiple comparison test, ***, P = 0.0005 for time in search mode, *, P = 0.0124 for time in running mode. (E) Percentage of cells with persistent steps (θ < 60° for δ < 45°). n = 9 larvae for DMSO, n = 5 larvae for CK666, and n = 4 larvae for Blebbistatin. Wilcoxon matched-pairs signed rank test, *, P = 0.0195 for DMSO, P = 0.0216 for Blebbistatin. (F) Mean instantaneous speed for movement towards (TW) or away (AW) from the wound, for pre- and post-LW. n = 1,334–2,292 cell steps per condition for DMSO (9 larvae), n = 1,056–1,616 cell steps per condition for CK666 (5 larvae), and n = 818–1,826 cell steps per condition for Blebbistatin (4 larvae). Kruskal-Wallis test with Dunn’s multiple comparison test, ****, P < 0.0001 for both DMSO and CK666. (G) Persistence of cells for 3 min (left) and 6 min (right) after neutrophil movement for DMSO, CK666, and Blebbistatin. One-way ANOVA with Dunnett’s multiple comparisons test, **, P = 0.0004 (3 min, DMSO-Blebbistatin), *, P = 0.0154 (6 min, DMSO-CK666), ***, P = 0.0002 (6 min, DMSO-Blebbistatin). (B–D and G) Data from n = 17 cells from 8 larvae for DMSO, n = 11 cells from 5 larvae for CK666, and n = 13 cells from 4 larvae for Blebbistatin. Mean and SEM are shown. |